Copyright
©The Author(s) 2025.
World J Transplant. Jun 18, 2025; 15(2): 99241
Published online Jun 18, 2025. doi: 10.5500/wjt.v15.i2.99241
Published online Jun 18, 2025. doi: 10.5500/wjt.v15.i2.99241
Table 2 Retrospective studies published during 2019-2020 on venous thromboembolism following lung transplantation, n (%)
Ref. | Study groups | LT patients | VTE | PE/infarct | DVT | Risk factors | Survival | Remarks |
Zheng et al[22], 2020 | SLT: 143; DLT: 78 | 197 | 47 (23) | NA | NA | Prophylaxis interruption | NA | UL DVT: 55% and VTE 70% in 30 days |
Jorge et al[23], 2020 | Group I (2005-2008): No DVT screening. Group II (2008-2014): DVT screening | NA | NA | NA | NA | High cholesterol had 6.9 times risk of DVT | Better survival in group II due to routine screening | NA |
Zhao et al[31], 2019 | SLT: 78; DLT: 46 | 124 | 32 (26) | 4 (3) | 30 (97) | ECMO | NA | 2 patients had both PE and DVT. No effect due to PICC |
Fan et al[24], 2019 | NA | 316 | 19 (6) | NA | NA | Age, SLT, long ICU stay | NA | VTE much higher without prophylaxis |
- Citation: Sunder T, Thangaraj PR, Kuppusamy MK. Venous thromboembolism following lung transplantation. World J Transplant 2025; 15(2): 99241
- URL: https://www.wjgnet.com/2220-3230/full/v15/i2/99241.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i2.99241